Neurovascular effects of L-carnitine treatment in diabetic rats

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 239-244

  Cameron, Norman E ^a   Cotter, Mary A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Blood flow; Diabetic rat; L Carnitine; Nerve conduction; Nitric oxide (NO)

Indexed keywords

CARNITINE; N(G) NITROARGININE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; MALE; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARNITINE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; MALE; NEURAL CONDUCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PERIPHERAL NERVES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SCIATIC NERVE;

EID: 0031015565     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00844-8     Document Type: Article

References (31)

1. Archibald, V., M.A. Cotter, A. Keegan and N.E. Cameron, 1996, Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments, Naunyn-Schmiedeberg's Arch. Pharmacol. 353, 584.
2. Bravenboer, B., A.C. Kapelle, F.P.T. Hamers, T. Van Buren, D.W. Erkelens and W.H. Gispen, 1992, Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat, Diabetologia 35, 813.
3. Cameron, N.E. and M.A. Cotter, 1992, Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway activity, Diabetologia 35, 1011.
4. Cameron, N.E. and M.A. Cotter, 1994, The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications, Diabetes Metab. Rev. 10, 189.
5. Cameron, N.E. and M.A. Cotter, 1995, Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats, Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 685.
6. Cameron, N.E. and M.A. Cotter, 1996a, Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats, Diabetologia 39, 1047.
7. Cameron, N.E. and M.A. Cotter, 1996b, Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition, Metabolism 45, 1147.
8. +-ATPase activity, and vascular supply in STZ-D rats, Diabetes 40, 1652.
9. Cameron, N.E., M.A. Cotter and P.A. Low, 1991b, Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits, Am. J. Physiol. 261, E1.
10. Cameron, N.E., M.A. Cotter, K.C. Dines and E.K. Maxfield, 1993, Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization, Diabetologia 36, 516.
11. Cameron, N.E., M.A. Cotter, V. Archibald, K.C. Dines and E.K. Maxfield, 1994a, Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats, Diabetologia 37, 449.
12. Cameron, N.E., M.A. Cotter, K.C. Dines, E.K. Maxfield, F. Carey and D.J. Mirrlees, 1994b, Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism, Diabetologia 37, 651.
13. Cameron, N.E., M.A. Cotter and T.C. Hohman, 1996, Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats, Diabetologia 39, 172.
14. Cohen, R.A., 1993, Dysfunction of vascular endothelium in diabetes mellitus, Circulation 87 (Suppl. 5), V-67.
15. Cotter, M.A., N.E. Cameron, A. Keegan and K.C. Dines, 1995a, Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes, Metabolism 44, 1209.
16. Cotter, M.A., A. Love, M.J. Watt, N.E. Cameron and K.C. Dines, 1995b, Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats, Diabetologia 38, 1285.
17. Fariello, R.G. and F. Calabrese, 1988, Prevention of ischemia-induced increase in malonaldehyde by acetyl carnitine, Ann. Neurol. 24, P114.
18. Ido, Y., J. McHowat, K.C. Chang, E. Arrigoni-Martelli, Z. Orfalian, C. Kilo, P.B. Corr and J.R. Williamson, 1994, Neural dysfunction and metabolic imbalances in diabetic rats: prevention by acetyl-L-carnitine, Diabetes 43, 1469.
19. Keegan, A., H. Walbank, M.A. Cotter and N.E. Cameron, 1995, Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta, Diabetologia 38, 1475.
20. Kunisaki, M., S. Bursell, F. Umeda, H. Nawata and G.L. King, 1994, Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels, Diabetes 43, 1372.
21. Lowitt, S., J.I. Malone, A. Salem, W.M. Kozak and Z. Orfalian, 1993, Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes, Diabetes 42, 1115.
22. Lowitt, S., J.I. Malone, A.F. Salem, J. Korthals and S. Benford, 1995, Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes, Metabolism 44, 677.
23. Mayhan, W.G. and K.P. Patel, 1995, Acute effects of glucose on reactivity of cerebral microcirculation: role of activation of protein kinase C, Am. J. Physiol. 269, H1297.
24. Shimamoto, Y., H. Shimamoto, C. Kwan and E.E. Daniel, 1993, Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle, Am. J. Physiol. 264, H1300.
25. Siliprandi, N., D. Siliprandi and M. Ciman, 1965, Stimulation of oxidation of mitochondrial fatty acids and of acetate by acetylcarnitine, Biochem. J. 96, 777.
26. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat, J. Clin. Invest. 94, 853.
27. Stevens, M.J., S.A. Greene, E.L. Feldman, A.A.F. Sima and D.A. Greene, 1995, Potential effects of acetyl-L-carnitine on sciatic nerve function in the streptozotocin-diabetic rat, in: Diabetic Neuropathy, New Concepts and Insights, eds. N. Hotta, D.A. Greene, J.D. Ward, A.A.F. Sima and A.J.M. Boulton (Elsevier, Amsterdam) p. 243.
28. Taglialatela, G., L. Angelucci, M.T. Ramacci, K. Werrbach-Perez, G.R. Jackson and J.R. Perez-Polo, 1991, Acetyl-L-carnitine enhances the response of PC12 cells to nerve growth factor, Dev. Brain Res. 59, 221.
29. Tesco, G., S. Latorraca and P. Piersanti, 1992, Protection from oxygen radical damage in human diploid fibroblasts by acetyl-L-carnitine, Dementia 3, 58.
30. Williamson, J.R. and E. Arrigoni-Martelli, 1992, The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction, Int. J. Clin. Pharmacol. Res. 12, 247.
31. Yagihashi, S., 1995, Pathology and pathogenetic mechanisms of diabetic neuropathy, Diabetes Metab. Rev. 11, 193.